Dr. Iris Jaffe

Dr. Jane A. Leopold is the director of the Women's Interventional Cardiology Health Initiative at Brigham and Women’s Hospital (BWH). An interventional cardiovascular medicine specialist, she is also an associate professor of medicine at Harvard Medical School (HMS).She received her medical degree at Boston University School of Medicine. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and two fellowships at Boston Medical Center—cardiovascular disease and interventional cardiology. Dr. Leopold is board certified in cardiovascular disease and interventional cardiology.Dr. Leopold developed the Women’s Interventional Cardiology Health Initiative at BWH, which uses advanced invasive diagnostic imaging and functional assessment devices to diagnose chest pain syndromes in women. The author of over 100 peer-reviewed publications, Dr. Leopold’s research interests include preclinical and clinical studies in pulmonary arterial hypertension and she is the principal investigator of a National Institutes of Health funded center at BWH to perform deep phenotyping in patients with Groups 1-5 pulmonary hypertension. She also studies mechanisms by which aldosterone influences vascular structure and function and cardiovascular disease in women. Her research has received support from the National Institutes of Health and the American Heart Association. Dr. Leopold is rated as a Distinguished provider by MediFind in the treatment of Vasoconstriction. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Attack, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Jeong Kim is an Advanced Heart Failure and Transplant Cardiologist and a Cardiac Electrophysiologist in Fall River, Massachusetts. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Vasoconstriction. His top areas of expertise are Coronary Heart Disease, Unstable Angina, Cardiogenic Shock, and Vasoconstriction. Dr. Kim is currently accepting new patients.

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS).Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease.The author of some 400 original peer-reviewed publications, some 450 reviews, chapters, or other publications, Dr. Libby also serves as an Editor of the leading textbook of cardiovascular medicine.  Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventive cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Dr. Libby is perennially named a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, the Anitschkow award from the European Atherosclerosis Society, The Ernst Jung Gold Medal for Medicine, and the Earl Benditt award for vascular biology. Dr. Libby is rated as a Distinguished provider by MediFind in the treatment of Vasoconstriction. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Abdominal Aortic Aneurysm (AAA), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.